- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Terns Pharmaceuticals Inc (TERN)
Assess today's live Terns Pharmaceuticals Inc (TERN) share price, performance and insights using our live NASDAQ: TERN stock exchange data.
Analyse the historical data and Terns Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Terns Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Terns Pharmaceuticals (TERN) stock price today with other investors in the Terns Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TERN share price (ISIN: US8808811074) to enhance your trading decisions with our free investment tools and resources.
What Is the Terns Pharmaceuticals Inc Share Price Today?
The Terns Pharmaceuticals share price today is 38.520.
What Is the Stock Symbol for Terns Pharmaceuticals Inc
The stock symbol (or 'ticker') for Terns Pharmaceuticals Inc is "TERN."
What Stock Exchange Does Terns Pharmaceuticals Inc Trade On?
Terns Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Terns Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Terns Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Terns Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Terns Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Terns Pharmaceuticals (TERN) stock price today with other investors in the Terns Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TERN share price (ISIN: US8808811074) to enhance your trading decisions with our free investment tools and resources.
What Is the Terns Pharmaceuticals Inc Share Price Today?
The Terns Pharmaceuticals share price today is 38.520.
What Is the Stock Symbol for Terns Pharmaceuticals Inc
The stock symbol (or 'ticker') for Terns Pharmaceuticals Inc is "TERN."
What Stock Exchange Does Terns Pharmaceuticals Inc Trade On?
Terns Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Terns Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Terns Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.420
38.970
52 wk Range
1.865
48.260
TERN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.42038.970
52 wk Range
1.86548.260
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TERN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
58.125
Upside
+50.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Form 144 TERNS PHARMACEUTICALS INC For: 15 January
- Investing.com
- Form 8K Terns Pharmaceuticals Inc For: 22 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Terns Pharmaceuticals Company Profile
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Terns Pharmaceuticals Inc SWOT Analysis
Pivotal Data Ahead | Terns Pharmaceuticals approaches critical milestones for TERN-601 and TERN-701, with data releases set to potentially reshape the company's future |
Obesity Market Promise | Explore TERN-601's potential in the competitive oral GLP-1RA landscape, as Terns positions its candidate against established players and recent setbacks |
CML Treatment Innovation | Delve into TERN-701's promising efficacy in chronic myeloid leukemia, addressing unmet needs and showcasing Terns' expanding therapeutic reach |
Financial Strength | With a $315M cash position and analyst targets ranging from $14 to $34, Terns demonstrates financial stability amidst biotech market volatility |
Compare TERN to Peers and Sector
Metrics to compare | TERN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTERNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −44.4x | −5.2x | −0.6x | |
PEG Ratio | −3.48 | 0.00 | 0.00 | |
Price/Book | 14.7x | 4.0x | 2.6x | |
Price / LTM Sales | - | 2.6x | 3.3x | |
Upside (Analyst Target) | 50.7% | 68.3% | 45.0% | |
Fair Value Upside | Unlock | 9.7% | 6.5% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 58.125
(+50.90% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-0.27 / -0.3021
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Terns Pharmaceuticals (TERN) Share Price Today?
The live Terns Pharmaceuticals share price today is 38.520
What Stock Exchange Does Terns Pharmaceuticals (TERN) Trade On?
Terns Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Terns Pharmaceuticals?
The stock symbol (also called a 'ticker') for Terns Pharmaceuticals is "TERN."
What Is the Current Terns Pharmaceuticals Market Cap?
As of today, Terns Pharmaceuticals market capitalisation is 4.19B.
What Is Terns Pharmaceuticals's (TERN) Earnings Per Share (TTM)?
The Terns Pharmaceuticals EPS is currently -1.03 (Trailing Twelve Months).
When Is the Next Terns Pharmaceuticals Earnings Date?
Terns Pharmaceuticals's next earnings report will be released on 30 Mar 2026.
Is TERN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Terns Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Terns Pharmaceuticals Stock Split?
Terns Pharmaceuticals has split 0 times. (See the TERN stock split history page for full effective split date and price information.)
How Many Employees Does Terns Pharmaceuticals Have?
Terns Pharmaceuticals has 59 employees.
What is the current trading status of Terns Pharmaceuticals (TERN)?
As of 04 Feb 2026, Terns Pharmaceuticals (TERN) is trading at a price of 38.520, with a previous close of 38.520. The stock has fluctuated within a day range of 36.420 to 38.970, while its 52-week range spans from 1.865 to 48.260.
What Is Terns Pharmaceuticals (TERN) Price Target According to Analysts?
The average 12-month price target for Terns Pharmaceuticals is USD58.125, with a high estimate of USD70 and a low estimate of USD54. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +50.90% Upside potential.
What Is the TERN Premarket Price?
TERN's last pre-market stock price is 38.540. The pre-market share volume is 790.000, and the stock has decreased by 0.020, or 0.050%.
What Is the TERN After Hours Price?
TERN's last after hours stock price is 38.960, the stock has decreased by 0.440, or 1.140%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.